What top creators are saying about Tenax Therapeutics Inc.(TENX)
Biopharmaceutical company developing Levosimendan for heart failure
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Tenax Therapeutics Inc. in the last 30 days yet.
Top creators covering Tenax Therapeutics Inc. (TENX)
The 1 sources with the most insights about Tenax Therapeutics Inc. on Kazuha.
Latest insights about Tenax Therapeutics Inc. (TENX)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Monday, August 3, 2026
The speaker notes that it is a hard stock to short because the name is TENX, while researching its clinical data and mechanism of action.
Monday, August 3, 2026
The speaker notes that it is a hard stock to short because the name is TENX, while researching its clinical data and mechanism of action.
Discussed alongside Tenax Therapeutics Inc. (TENX)
Other assets that creators frequently mention in the same content as Tenax Therapeutics Inc..
Frequently asked
Which podcasters and creators cover Tenax Therapeutics Inc. (TENX) the most?
The most active sources covering Tenax Therapeutics Inc. (TENX) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Tenax Therapeutics Inc. (TENX) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Tenax Therapeutics Inc. (TENX) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Tenax Therapeutics Inc. (TENX)?
Creators covering Tenax Therapeutics Inc. (TENX) most frequently also discuss NVDA, INTC, MU, PLTR, QBTS. See the "Discussed alongside" section above for full asset pages.